• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Editorial Staff
    • Publication Ethics
    • Indexing and Abstracting
    • Related Links
    • FAQ
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Reviewers
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
The Medical Journal of Cairo University
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 89 (2021)
Issue March
Volume Volume 88 (2020)
Volume Volume 87 (2019)
Volume Volume 86 (2018)
KAREM F. ABDELMOETY, M.D., M., MOSTAFA, M.D., A. (2021). Comparative Study between Rivaroxaban and Warfarin inTreatment of Patients with Recurrent Deep Venous Thrombosis. The Medical Journal of Cairo University, 89(March), 199-207. doi: 10.21608/mjcu.2021.153789
MOHAMED M.R. YOUSEF, M.Sc.; KAREM F. ABDELMOETY, M.D.; ASHRAF A. MOSTAFA, M.D.. "Comparative Study between Rivaroxaban and Warfarin inTreatment of Patients with Recurrent Deep Venous Thrombosis". The Medical Journal of Cairo University, 89, March, 2021, 199-207. doi: 10.21608/mjcu.2021.153789
KAREM F. ABDELMOETY, M.D., M., MOSTAFA, M.D., A. (2021). 'Comparative Study between Rivaroxaban and Warfarin inTreatment of Patients with Recurrent Deep Venous Thrombosis', The Medical Journal of Cairo University, 89(March), pp. 199-207. doi: 10.21608/mjcu.2021.153789
KAREM F. ABDELMOETY, M.D., M., MOSTAFA, M.D., A. Comparative Study between Rivaroxaban and Warfarin inTreatment of Patients with Recurrent Deep Venous Thrombosis. The Medical Journal of Cairo University, 2021; 89(March): 199-207. doi: 10.21608/mjcu.2021.153789

Comparative Study between Rivaroxaban and Warfarin inTreatment of Patients with Recurrent Deep Venous Thrombosis

Article 25, Volume 89, March, March 2021, Page 199-207  XML PDF (493.91 K)
DOI: 10.21608/mjcu.2021.153789
Authors
MOHAMED M.R. YOUSEF, M.Sc.; KAREM F. ABDELMOETY, M.D.; ASHRAF A. MOSTAFA, M.D.
The Department of General Surgery, Faculty of Medicine, Ain Shams University
Abstract
AbstractBackground: Venous Thrombo-Embolism (VTE) manifestsas Deep Venous Thrombosis (DVT) and/or Pulmonary Em-bolism (PE). Per 1000 persons in the general population, theannual incidence is 1 to 2 cases. For decades, the gold standard of anti-thrombotic therapy has been based on heparins and Vitamin K Antagonists (VKAs), their narrow therapeutic range and multiple interactions led to the development of New Oral Anticoagulants (NOACs) beginning in 2003. Two types of new anticoagulants have been developed: Direct factor Xa inhibitors (Rivaroxaban) and direct factor IIa (thrombin) inhibitors.Aim of Study: The aim of this study was to comparerivaroxaban versus warfarin in treatment of recurrent DVTas regard efficacy, safety and complications.Patients and Methods: This was a prospective studyconducted on 30 patients suffering from recurrent deep venousthrombosis. The studied cases were divided into two groups,Group A treated by rivaroxaban, while group B treated bywarfarin over a period of 6 months. All cases were subjectedto full history taking, complete general and local examination,routine laboratory investigations and Duplex Scanning.Results: No statistically significant differences amongrivaroxaban and warfarin groups as regards presence of riskfactors, DVT extension, duplex results and incidence ofcomplications, while there was significant difference as regardsduration till symptoms relief.Conclusion: Rivaroxaban seems to have same efficacyas warfarin with advantage being earlier in symptoms relief/days, recanalization and patient compliance. In addition,warfarin users need to be monitored regularly.
Keywords
Rivaroxaban; Warfarin; Recurrent DVT
Statistics
Article View: 22
PDF Download: 31
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.